Compare · 3 funds side by side · dividends reinvested

PCR, SPY and IVV

02 / 04

−0.1%

Search ETFs and stocks

Story of the three · Growth5Y$10,000 five years agoDividends reinvested · all three on one scale$17,265IVV · best of the three

Story of the three · IncomeMost incomePCR · 12.49% · $1,249 a year on $10k

Story of the three · RiskSmallest drop

PCR, SPY and IVV, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

iShares Core S&P 500 ETFLow-Cost Core · S&P 5000.03%1.11%+11.5%+11.6%+21.5%+11.5%−8.9%13.8%$875B1.4

State Street SPDR S&P 500 ETFLow-Cost Core · S&P 5000.09%1.01%+11.5%+11.6%+21.4%+11.5%−8.9%13.7%$807B1.9

Simplify VettaFi Private Credit Strategy ETFBonds & Cash · Corporate0.76%12.49%−15.4%−17.9%[…][…]−19.4%16.9%$2M2.7

Rank among the three1st → 3rdFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 13, 2026 · returns include dividends · since: PCR 2025 · SPY 1993 · IVV 2000

Head to Head

Swap sides Versus in desk

Head to Head

5Y

Simplify VettaFi Private Credit Strategy ETF · $2M[…]

PCR

IVV

iShares Core S&P 500 ETF · $875B$17,265

$10,000 five years ago, dividends reinvested

PCRMeasureIVV

More Ways to See the Pairs

PCR vs IVV: Top 5 Holdings

Today

PCR

[…]in top 5

IVV

in top 526.8%

PCRStockIVV

not top 5AAPL7.9%

not top 5NVDA6.4%

not top 5MSFT5.9%

not top 5AMZN4.0%

not top 5GOOGL2.6%

Cost, Income and Risk

Fees: PCR, SPY, IVV

Today

0.03%lowest, IVV

FundExpense ratioFee$10k

IVV0.03%$3

SPY0.09%$9

PCR0.76%$76

End-of-day Nov 13, 2026 · fee on $10,000 a year

Yields: PCR, SPY, IVV

Popular Pairs Near These Three

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$186BAssets$807B

0–0level

End-of-day Nov 13, 2026

VOO vs IVV

YTD

VanguardVOO

+11.5%

IVViShares

+11.5%

SCHD vs VIG

YTD

SchwabSCHD

+34.9%

VIGVanguard

+16.0%

−15.4%Year to dateJan 1 → Nov 13+11.5%

−17.9%1 yearTotal return+11.6%

[…]3 years · per year$10,000 became […] · $17,931+21.5%

[…]5 years · per year$10,000 became […] · $17,265+11.5%

0.76%Expense ratio$76 · $3 a year on $10k · lower is better0.03%

12.49%Trailing 12-mo yield$1,249 · $111 a year on $10k1.11%

−19.4%Worst dropSmaller is better−8.9%

16.9%VolatilityLower is calmer13.8%

PCRIVV Winner of the row, in its colourEach row: the bigger of the two fills its side

1–5IVV wins

End-of-day Nov 13, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

Held in common[…]

End-of-day Nov 13, 2026 · share of each fund

PCR vs IVV Returns, Every Period

1Y

SimplifyPCR

−17.9%

past year

IVViShares

+11.6%

past year

PCRIVVFaded: behind in that period

0–2IVV wins

End-of-day Nov 13, 2026 · dividends in · faded = behind in that period

Bonds vs Core: PCR vs IVV

YTD

SimplifyPCR

−15.4%

IVViShares

+11.5%

−15.4%Year to date+11.5%

−19.4%Worst drop · 1Y−8.9%

16.9%Volatility · 1Y13.8%

12.5%Yield1.1%

$2.2MAssets$875B

3–1IVV wins

End-of-day Nov 13, 2026 · smaller drop and lower volatility win

1Y

12.49%highest, PCR

FundTrailing yieldYield$10k

PCR12.49%$1,249

IVV1.11%$111

SPY1.01%$101

End-of-day Nov 13, 2026 · trailing 12-month yield

Income After Fees on $10,000

1Y

$1,173most kept, PCR

PCR$1,249 − $76 = $1,173

IVV$111 − $3 = $108

SPY$101 − $9 = $92

KeptFee

End-of-day Nov 13, 2026 · yield in dollars minus the fee

Overlap: PCR, SPY, IVV

Today

99.9%most shared, SPY and IVV

PCRSPYIVV

PCR—[…][…]

SPY[…]—99.9%

IVV[…]99.9%—

End-of-day Nov 13, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 3 ETFs

1Y

+11.6%IVV, at 13.8% volatility

SPYWorst drop−8.9%13.7% vol

IVVWorst drop−8.9%13.8% vol

PCRWorst drop−19.4%16.9% vol

End-of-day Nov 13, 2026 · up and left is better

Paid More vs Made More

YTD

PCRIVV

−15.4%Year to date+11.5%

12.5%Yield1.1%

−17.9%Past year+11.6%

0.76%Fee0.03%

3–1IVV wins

End-of-day Nov 13, 2026

Year to date

+11.5%

1.1%Yield1.1%

$1.00TAssets$875B

0–0level

End-of-day Nov 13, 2026

+34.9%Year to date+16.0%

2.9%Yield1.4%

$124BAssets$109B

2–0SCHD wins

End-of-day Nov 13, 2026

Loading…

PCR, SPY and IVV

Head to Head

More Ways to See the Pairs

Cost, Income and Risk

Popular Pairs Near These Three